Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stoeckel

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1989
Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjectsR A Blouin, J Kneer, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1996
Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newbornK Stoeckel, P H Joubert, J Grüter
European Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerationsP J McNamara, M Gibaldi, K Stoeckel
Biochemical Pharmacology|September 15, 1990
Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepamP J McNamara, V Trueb, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significanceP J McNamara, M Gibaldi, K Stoeckel
Journal of Pharmaceutical Sciences|July 1, 1983
Fraction unbound in interstitial fluidP J McNamara, M Gibaldi, K Stoeckel
Journal of Neurochemistry|June 1, 1976
Purification of nerve growth factor antibodies by affinity chromatographyK Stoeckel, C Gagnon, G Guroff, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1992
Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxilN H Holford, R J Ambros, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g doseP J McNamara, K Stoeckel, W H Ziegler
Brain Research|September 17, 1976
Selective uptake and retrograde axonal transport of dopamine-beta-hydroxylase antibodies in peripheral adrenergic neuronsM Fillenz, C Gagnon, K Stoeckel, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|March 1, 1989
Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjectsR A Blouin, J Kneer, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1996
Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newbornK Stoeckel, P H Joubert, J Grüter
European Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerationsP J McNamara, M Gibaldi, K Stoeckel
Biochemical Pharmacology|September 15, 1990
Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepamP J McNamara, V Trueb, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significanceP J McNamara, M Gibaldi, K Stoeckel
Journal of Pharmaceutical Sciences|July 1, 1983
Fraction unbound in interstitial fluidP J McNamara, M Gibaldi, K Stoeckel
Journal of Neurochemistry|June 1, 1976
Purification of nerve growth factor antibodies by affinity chromatographyK Stoeckel, C Gagnon, G Guroff, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1992
Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxilN H Holford, R J Ambros, K Stoeckel
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g doseP J McNamara, K Stoeckel, W H Ziegler
Brain Research|September 17, 1976
Selective uptake and retrograde axonal transport of dopamine-beta-hydroxylase antibodies in peripheral adrenergic neuronsM Fillenz, C Gagnon, K Stoeckel, et al.
Pageof 7